Angiogenesis is a process to form new blood vessels, which is tightly regulated by a balance between positive and negative factors [1] 
. The rotenoid, deguelin, is isolated from several plant species, including Mundulea sericea (Leguminosae) [9] . Deguelin has also shown potential as a chemopreventive agent against breast, colon, skin and non-small cell lung cancers [7] [8] [9] [10] [11] [12] [13] [14] [15] . We have demonstrated that deguelin, a natural product isolated from plants in the Mundulea sericea family, inhibits cyclooxygenase-2 expression and phosphatidylinositol 3-kinase (PI3K)/Akt-mediated signalling pathways which contribute to its anti-proliferative effects [10] [11] [12] [13] . However, we also found out that deguelin reduces the expression of Hsp90-binding proteins, including hypoxia inducible factor (HIF)-1␣ protein and induced the degradation of HIF-1␣ protein independently on reactive oxygen species and PI3K-Akt pathways [14] . Recently, we proposed deguelin as a novel anti-angiogenic anticancer agent to decrease the expression of HIF-1␣ protein and its target angiogenic cytokine in vascular endothelial cells under hypoxic conditions [15] . Moreover, deguelin inhibited de novo synthesis of HIF-1␣ protein and reduced the half-life of the synthesized protein [15] .
In [10] [11] [12] [13] [14] 
the present study, we demonstrated deguelin significantly reduces retinal neovascularization in OIR. The anti-angiogenic activity of deguelin was related to the reduction of HIF-1␣ and vascular endothelial growth factor (VEGF) expression without change in transcriptional activity of HIF-1␣. Up to 1 µm deguelin, 10 times of effective therapeutic concentration of it, deguelin never affected the viability of human retinal endothelial cells (HRECs). Moreover, it also showed no significant toxicity in the physiological retinal vascular formation and in the developing retina. In addition to the anti-proliferative activity of deguelin to cancer cells

Oxygen-induced retinopathy
OIR was induced as described by Smith et al. [6] with some modifications [16] . Briefly, newborn mice were randomly assigned to experimental and control groups. At postnatal day (P) 7, 
Luciferase assay
Luciferase assay using pSV40pro-EpoHRE-Luc vector was performed as described in our previous experiments [17] . The 
Cell viability assay
Cell viability was evaluated with the 3-(4,5-dimethylthiazol-2-yl)-2,5-
Results
Effect of deguelin in retinal neovascularization in OIR
We determined whether deguelin could reduce retinal neovascularization in oxygen-induced retinopathy. In the mouse OIR [6, 18, 19] . Based on our previous data [14, 15] , we injected deguelin (0.1 µm/1µl) intravitreously on P14 when active neovascularization occurs [18, 19] . (Fig. 1A) In contrast, retinas from P17 deguelin-treated mice showed significantly reduced neovascularization. (Fig. 1B) To quantify the intravitrous neovascularization, vascular lumens between posterior surface of lens and anterior surface of the inner limiting membrane were counted in a masked fashion.
Fig. 3 Effects of deguelin on HIF-1␣ transcriptional activity and the expression of HIF-1␣ and VEGF. (A) HEK 293 cells were cotransfected with 1 µg of pSV40promoter-EpoHRE-Luc reporter plasmid and 1 µg of the pSV-␤-galactosidase plasmid and then allowed to recover for 24 hrs after transfection. With treatment of deguelin (0~10 µM), transfected cells were incubated for 16 hrs before exposing them to hypoxia or maintaining them in normoxia and assayed for luciferase and ␤-galactosidase activities. The relative luciferase activity refers to the ratio of RLU/␤-galactosidase measured in hypoxiatreated cells compared to normoxic cells. (B) HEK 293 cells were incubated for 16 hrs before exposing them to hypoxia or maintaining them in normoxia and assayed for the expression of HIF-1␣ and vascular endothelial growth factor (VEGF). Quantitative analysis was performed by measuring protein expression relative to the control. Each value represents the mean (±SD) of three independent experiments, each performed in triplicate (*P<0.05). model, P7 newborn mice are kept in hyperoxia (75% oxygen) for 5 days. Excessive oxygen results in promoting the obliteration of existing vessels and blocking the development of retinal vasculature. After 5 days of hyperoxia, with back to room air, the undervascularized retina promotes the production of pro-angiogenic factors which drive the growth of abnormal new blood vessels
To visualize intravitreous neovascularization in OIR, fluorescein angiography using fluorescein-conjugated dextran was performed. P17 deguelin-treated and control mice subjected to OIR showed that peripapillary, central retinal capillaries dropped out, whereas the large, radial retinal vessels extending to the periphery persisted. Retinas from P17 control mice contained many neovascular tufts of intravitreous neovascularization at the junction between the vascualrized and non-vascularized retina.
Retinas from P17 control mice demonstrated multiple neovascular lumens, (Fig. 2A) (Fig. 3A) As our previous report [15] , 0.1 µm deguelin reduced HIF-1␣ expression under hypoxic condition, which led to the decrease of VEGF expression (P<0.05). (Fig. 3B) 
Effect of deguelin on the viability of HRECs
To investigate cytotoxic effect of deguelin on HRECs, MTT assay was carried out in various concentrations of deguelin (0~10 µm).
The viability of HRECs treated with deguelin was not affected up to 1 µm. (Fig. 4) 0.1 µm deguelin, effective therapeutic concentration to inhibit VEGF expression in our previous report [14, 15] , did not affect the viability of HRECs.
Effect of deguelin on physiological retinal angiogenesis in development
After intravitreal injection of 1 µM deguelin, 10 times of effective therapeutic concentration of deguelin, physiologic retinal angiogenesis was evaluated through immunohistochemistry for vWF. In the mouse retinal vasculature development, the primary vascular network spreads approximately halfway across the inner surface of the retina by P4 and reaches the periphery approximately 1 week (P7) after birth. After the vascular network has spread across the entire retina, arteries and veins strictly alternate and, at approximately P7, start to sprout downward, into the inner plexiform layer, where they establish a second vascular network parallel to the first by P14 [20] .
As demonstrated in Figure 5A, [14, 15] .
In 
